1 Posts
0 Comments

Terry Chrisomalis

BioMarin: Voxzogo Gross sales Surge Is not Solely Driving Pressure In 2024 (NASDAQ:BMRN)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has been capable of enormously capitalize on gross sales of its authorised drug Voxzogo for the therapy of sufferers with achondroplasia. The rationale was that...

Latest articles

spot_img

Sign up to receive news and updates

To be updated with all the latest news, offers and special announcements.

By signing up you agree to receive email newsletters, notifications and alerts from Covid Dark PRO. You can unsubscribe at any time.
WP2Social Auto Publish Powered By : XYZScripts.com